| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |